Literature DB >> 29680103

Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.

Zhihao Yang1, Nan Luo2, Gouke Bonsel3, Jan Busschbach4, Elly Stolk5.   

Abstract

BACKGROUND: For many countries, the three-level EuroQol five-dimensional questionnaire (EQ-5D-3L) value sets have been established to estimate health state utilities. To generate these value sets, researchers first collect values for a subset of preselected health states from a panel representing the general public, and then use a prediction algorithm to generate values for all 243 states. High prevalence of a health state in daily practice has historically been a key criterion in selecting a subset of health states as the observed set. More recently, other criteria have been suggested, especially approaches based on statistical criteria such as randomization and orthogonality.
OBJECTIVES: To evaluate the validity and accuracy of both the earlier and newer criteria, in terms of prediction of values for all the health states and of the values of common health states in particular.
METHODS: We used a pre-existing data set that contained visual analogue scale values from 126 students, each of whom valued all 243 EQ-5D-3L states. Then, we generated a series of designs and subsequently modeled the data with respect to each design. Some of these designs were used in the past; for example, the Measurement and Valuation of Health approach was included. Others were newly generated. The performance of different designs was evaluated in terms of the lowest root mean squared error for all health states taken together, and separately for common and rare states. Classification as common or rare was based on the frequency of the states' occurrence in three patient and population data sets pooled together (N = 5269).
RESULTS: The orthogonal design with 54 health states produced the lowest root mean squared errors. Over-representation of common health states in a design did not improve the estimations for these states. The published designs performed the worst, whereas the random selection designs were good on average. Nevertheless, the performance of the random selection designs showed more variance compared with orthogonal designs, because some of the former designs did not display appropriate balance.
CONCLUSIONS: The published designs gave rise to large estimation errors for the extrapolated EQ-5D-3L health states. The orthogonal design focusing on statistical efficiency showed its superiority. Overall, when weighing up design properties, increased statistical efficiency outweighs an increased error rate, if any, in rare health states.
Copyright © 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EQ-5D-3L; common health state; orthogonal design; value set

Mesh:

Year:  2017        PMID: 29680103     DOI: 10.1016/j.jval.2017.09.001

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  5 in total

1.  In a Child's Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives.

Authors:  Stefan A Lipman; Brigitte A B Essers; Aureliano P Finch; Ayesha Sajjad; Peep F M Stalmeier; Bram Roudijk
Journal:  Pharmacoeconomics       Date:  2022-10-18       Impact factor: 4.558

2.  More Unnecessary Imaginary Worlds - Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell Disease.

Authors:  Paul C Langley
Journal:  Innov Pharm       Date:  2020-04-30

3.  Value Assessment in Cystic Fibrosis: ICER's Rejection of the Axioms of Fundamental Measurement.

Authors:  Paul C Langley
Journal:  Innov Pharm       Date:  2020-04-30

4.  A Value Set for the EQ-5D-Y-3L in the Netherlands.

Authors:  Bram Roudijk; Ayesha Sajjad; Brigitte Essers; Stefan Lipman; Peep Stalmeier; Aureliano Paolo Finch
Journal:  Pharmacoeconomics       Date:  2022-10-10       Impact factor: 4.558

Review 5.  Influential Usage of Big Data and Artificial Intelligence in Healthcare.

Authors:  Yan Cheng Yang; Saad Ul Islam; Asra Noor; Sadia Khan; Waseem Afsar; Shah Nazir
Journal:  Comput Math Methods Med       Date:  2021-09-06       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.